Summary information

Study title

COVID-19 Survey in Five National Longitudinal Cohort Studies: MRC National Survey of Health and Development, 2020-2021: Special Licence Access

Creator

University College London, MRC Unit for Lifelong Health and Ageing

Study number / PID

8732 (UKDA)

10.5255/UKDA-SN-8732-3 (DOI)

Data access

Restricted

Series

Not available

Abstract

Abstract copyright UK Data Service and data collection copyright owner.The Centre for Longitudinal Studies (CLS) and the MRC Unit for Lifelong Health and Ageing (LHA) have carried out two online surveys of the participants of five national longitudinal cohort studies which have collected insights into the lives of study participants including their physical and mental health and wellbeing, family and relationships, education, work, and finances during the coronavirus pandemic. The Wave 1 Survey was carried out at the height of lockdown restrictions in May 2020 and focussed mainly on how participants’ lives had changed from just before the outbreak of the pandemic in March 2020 until then. The Wave 2 survey was conducted in September/October 2020 and focussed on the period between the easing of restrictions in June through the summer into the autumn. A third wave of the survey was conducted in early 2021.In addition, CLS study members who had participated in any of the three COVID-19 Surveys were invited to provide a finger-prick blood sample to be analysed for COVID-19 antibodies. Those who agreed were sent a blood sample collection kit and were asked to post back the sample to a laboratory for analysis. The antibody test results and initial short survey responses are included in a single dataset, the COVID-19 Antibody Testing in the National Child Development Study, 1970 British Cohort Study, Next Steps and Millennium Cohort Study, 2021 (SN 8823).The CLS studies are:Millennium Cohort Study (born 2000-02) both cohort members and parents (MCS)Next Steps (born 1989-90) (NS)1970 British Cohort Study (BCS70)1958 National Child Development Study (NCDS).The LHA study is:MRC National Survey of Health and Development, 1946 British birth cohort (NSHD)The content of the MCS, NS, BCS70 and NCDS COVID-19 studies, including questions, topics and variables can be explored via the CLOSER Discovery website. The COVID-19 Survey in Five National Longitudinal Cohort Studies:...
Read more

Methodology

Data collection period

03/05/2020 - 30/04/2021

Country

United Kingdom

Time dimension

Repeated cross-sectional study

Analysis unit

Individuals
National

Universe

All cohort members from the five cohort studies (NSHD, NCDS, BCS70, Next Steps and MCS) for whom an email address was held were selected for issue, provided that they a) had not permanently withdrawn from the study b) were not ‘permanently untraced’ and c) were not known to have died. NSHD: All births in England, Scotland, and Wales that occurred in one week in March 1946. NCDS: All births in England, Wales, and Scotland, during one week in 1958. BCS70: All births in England, Wales, and Scotland during one week in 1970. Next Steps: Young people born between 1st September 1989 and 31st August 1990 who were in Year 9 in English state and independent schools and pupil referral units in February 2004. MCS: A stratified sample of babies born between 1 September 2000 and 31 August 2001 in England and Wales, and 23 November 2000 and 11 January 2002 in Scotland and Northern Ireland. MCS Parents were contacted separately.

Sampling procedure

No sampling (total universe)

Kind of data

Numeric

Data collection mode

Self-administered questionnaire: Web-based (CAWI)

Funding information

Grant number

MC_UU_00019/1

Grant number

ES/M001660/1

Access

Publisher

UK Data Service

Publication year

2020

Terms of data access

The Data Collection is available to users registered with the UK Data Service.

Commercial use is not permitted.

Use of the data requires approval from the data owner or their nominee. Users must apply for access via a Special Licence application.

This data must not be accessed at a location outside European Economic Area or outside the following countries deemed by the European Commission to have an adequate level of data protection: Andorra, Argentina, Faroe Islands, Guernsey, Israel, Isle of Man, Japan, Jersey, New Zealand, Switzerland and Uruguay.

Related publications

Not available